Affiliation:
1. Department of Cell and Molecular Biology, Tulane University, New Orleans, LA, 70118
2. Center for Biomedical Research of South China, Fujian Key Laboratory of Developmental and Neuro Biology, College of Life Science, Fujian Normal University, Fuzhou, Fujian Province, China
Abstract
Background
Inactivation of
Shox2
, a member of the short‐stature homeobox gene family, leads to defective development of multiple organs and embryonic lethality as a result of cardiovascular defects, including bradycardia and severe hypoplastic sinoatrial node (
SAN
) and sinus valves, in mice. It has been demonstrated that
Shox2
regulates a genetic network through the repression of
Nkx2.5
to maintain the fate of the
SAN
cells. However, the functional mechanism of Shox2 protein as a transcriptional repressor on
Nkx2.5
expression remains completely unknown.
Methods and Results
A specific interaction between the B56δ regulatory subunit of
PP
2A and Shox2a, the isoform that is expressed in the developing heart, was demonstrated by yeast 2‐hybrid screen and coimmunoprecipitation. Western blotting and immunohistochemical assays further confirmed the presence of phosphorylated Shox2a (p‐Shox2a) in cell culture as well as in the developing mouse and human
SAN
. Site‐directed mutagenesis and in vitro kinase assays identified Ser92 and Ser110 as true phosphorylation sites and substrates of extracellular signal‐regulated kinase 1 and 2. Despite that Shox2a and its phosphorylation mutants possessed similar transcriptional repressive activities in cell cultures when fused with Gal4 protein, the mutant forms exhibited a compromised repressive effect on the activity of the mouse
Nkx2.5
promoter in cell cultures, indicating that phosphorylation is required for Shox2a to repress
Nkx2.5
expression specifically. Transgenic expression of
Shox2a
, but not
Shox2a‐S92
AS
110A
, mutant in the developing heart resulted in down‐regulation of
Nkx2.5
in wild‐type mice and rescued the
SAN
defects in the
Shox2
mutant background. Last, we demonstrated that elimination of both phosphorylation sites on Shox2a did not alter its nuclear location and dimerization, but depleted its capability to bind to the consensus sequences within the
Nkx2.5
promoter region.
Conclusions
Our studies reveal that phosphorylation is essential for Shox2a to repress
Nkx2.5
expression during
SAN
development and differentiation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献